About: CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 June 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2006 (uk) artículu científicu espublizáu en xunu de 2006 (ast) scientific article published on 09 June 2006 (en)
publication date	wds:Q83967302-AEB19FE3-AE64-4924-9B93-E3C3E5354B3B
publication date	2006-06-09 00:00:00Z (xsd:dateTime)
author name string	wds:Q83967302-023C9D44-6E5D-4010-BD9B-405B5A465D72 wds:Q83967302-037BBAD9-AB9F-481F-A2B1-53BC68B86A7C wds:Q83967302-057AA507-0A70-4C18-A63E-7F9E2744ACA7 wds:Q83967302-06A8E9D5-3FE1-4888-B28D-D963E5B84CBD wds:Q83967302-28D029C7-F1E9-4179-B2B0-170AC1942DA4 wds:Q83967302-2BAEF682-7FB8-4F41-A96E-6E3D1D510AD5 wds:Q83967302-5D655DEC-97C9-4A1B-9CB5-48149A4B22AE wds:Q83967302-97924B36-0DA1-4D3E-8679-58FB3C74307C wds:Q83967302-E7444B68-2129-4470-932C-B09693AD5682
author name string	J M Riedinger J P Basuyau M F Pichon N Eche J Wafflart K Hacene H Larbre G Ricolleau I Dalifard
rdfs:label	CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study (en) CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study (nl)
skos:prefLabel	CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study (en) CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study (nl)
name	CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study (en) CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study (nl)
title	wds:Q83967302-39118EDC-4C4C-4BDC-9A31-96122EC5D426
title	CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study (en)
page(s)	wds:Q83967302-A220E2F5-B2B5-41FA-8A50-4C4D6F63B0A5
page(s)	1234-1238
instance of	wds:Q83967302-7726DE64-562F-480B-8FB4-90EA2335F218
instance of	scholarly article
main subject	wds:Q83967302-B043156F-375C-4366-B89A-3247398CD203 wds:Q83967302-D4691CBC-1100-4B3E-86BE-176A7DC15B2F
main subject	ovarian neoplasm Mucin 16, cell surface associated
PubMed ID	wds:Q83967302-F738891A-55A1-4C13-8F41-2B04019B49DE
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16766592
PubMed ID	16766592
published in	wds:Q83967302-CD106C27-1614-448A-949D-555B07A1041F
published in	Annals of Oncology
issue	wds:Q83967302-7C7FAF08-FEEA-42AD-8A29-97C2349EF2B9
volume	wds:Q83967302-14429D2B-2F0B-4202-85D9-B242EB2C4221
issue	8
volume	17
DOI	wds:Q83967302-FC6A37BE-C2F3-45FE-805F-722BFDF9F1AB
DOI	http://dx.doi.org/10.1093/ANNONC/MDL120
DOI	10.1093/ANNONC/MDL120
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q83967302
is cites work of	Liquid biopsies: genotyping circulating tumor DNA Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial Importance of CA125 normalization during neoadjuvant chemotherapy followed by planned delayed surgical debulking in patients with epithelial ovarian cancer Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric study National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders Liquid biopsy: unlocking the potentials of cell-free DNA. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study. Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer Detection of circulating tumor cell DNA for monitoring advanced gastric cancer CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study Tumor DNA: an emerging biomarker in head and neck cancer Developing biomarker-specific end points in lung cancer clinical trials p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancer. The feasibility of using mutation detection in ctDNA to assess tumor dynamics CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer Granulin: biomarker or interesting window into host/tumor biology? The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study). A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods. The Effect of CA125 Nadir Level on Survival of Advanced-Stage Epithelial Ovarian Carcinoma after Interval Debulking Surgery. CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review
is cites work of	wds:Q39279845-852C4136-0E1E-4A16-85D3-410D86F922DA wds:Q37983980-337B1564-BAB7-478C-8744-30668378CE68 wds:Q41469418-0C513440-EF15-4838-BE70-63E35E082473 wds:Q90640909-809F46D0-1AD6-4546-8BC7-96A4A30DFDC9 wds:Q33697983-BE577DBA-8F9F-4CED-8B17-7629F784AAD5 wds:Q44774158-30B9F567-3607-4124-A417-56330CDE35A4 wds:Q30505345-A538E3C7-1B2D-45DB-BD75-FC0F9C3F650E wds:Q37486159-85489029-C897-400F-B7AB-AC0DD2FB40A2 wds:Q53468294-D80AB22C-D244-47FD-9173-20A8ECAC5762 wds:Q82735001-EC12EE5B-EFD8-4E44-9A3C-45D8476E626D wds:Q34221652-47EB7F51-E4C7-4D5C-AB61-FAB764640A3E wds:Q30630234-C2D9F0A6-D913-4A0E-ADB0-E74D5A925CA5

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software